Skip to main content
Clinical Trials/NCT03676205
NCT03676205
Completed
Phase 2

Randomized Clinical Trial About the Therapeutic Use of Platelet-Rich Plasma (PRP) for the Treatment of Acute Muscular Injuries in Football Players.

University of the Basque Country (UPV/EHU)1 site in 1 country41 target enrollmentOctober 3, 2016
ConditionsMuscle Injury

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Muscle Injury
Sponsor
University of the Basque Country (UPV/EHU)
Enrollment
41
Locations
1
Primary Endpoint
Pain intensity
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

OBJECTIVE: To evaluate the effect of Platelet Rich Plasma (PRP) injection in muscle injuries. The investigators check football players in the acute phase of hamstrings or quadriceps injuries.

Efficacy and safety are evaluated. There are two intramuscular infiltration of PRP (Ortho pras ® system) or a homeopathic product (Traumeel ®) in each of the football players. The number of days between the date of injury and the return to play, the pain, the recurrence and the adverse reactions are registered.

Detailed Description

STUDY DESIGN: Randomized Clinical Trial. METHODS: 41 football players are included in the study. It is used randomly PRP injection or a homeopathic product in muscle injuries (hamstring), in the early stage (first 48-72 hours). One week later, the investigators do a second infiltration with the same product, always ultrasound guided. 3-4 weeks after the injury, different variables are evaluated: the injurie with ultrasounds , self-perception test, muscle strength, flexibility, jump and run. It is compared the elapsed time in days in each of the groups: RETURN TO PLAY. Furthermore, the PAIN, RECURRENCE RATE and ADVERSE REACTIONS are evaluated.

Registry
clinicaltrials.gov
Start Date
October 3, 2016
End Date
January 8, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of the Basque Country (UPV/EHU)
Responsible Party
Principal Investigator
Principal Investigator

Javier González Iglesias

Medical Doctor (orthopedic surgeon)

University of the Basque Country (UPV/EHU)

Eligibility Criteria

Inclusion Criteria

  • Over 18 years old.
  • Acute muscular Injury Type 3a-3b (Múnich classification) in hamstring muscles
  • Informed consent signed

Exclusion Criteria

  • Hamstring injury (last 6 months).
  • Previous infiltration in hamstring.

Outcomes

Primary Outcomes

Pain intensity

Time Frame: 3 months since the injury

Pain after the muscle injury, and after the injections, with: -Funtional outcomes: pain (0 no pain; 10 unbearable pain) at rest, walking and going up and down the stairs. The Brief Pain Inventory - Short Form. Pain intensity (0, no pain - 10 unbearable) and interferences with the daily activities (0, does not interfere; 10, completely interferes).

Return to play (recovery period)

Time Frame: average of 3-6 weeks. Until play again a football match (training or competition)

Days elapsed since muscular injury apperars until the return to play

Secondary Outcomes

  • Number of adverse effects(Through study completion, an average of 1 year)
  • Incidence of Recurrences(Less than 6 months since the first injury)

Study Sites (1)

Loading locations...

Similar Trials